skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:056797/0633   Pages: 11
Recorded: 04/09/2021
Attorney Dkt #:14539-0001001
Conveyance: CHANGE OF ADDRESS
Total properties: 15
1
Patent #:
Issue Dt:
12/04/2007
Application #:
10830480
Filing Dt:
04/23/2004
Publication #:
Pub Dt:
02/10/2005
Title:
CASR ANTAGONIST
2
Patent #:
Issue Dt:
10/09/2012
Application #:
12837679
Filing Dt:
07/16/2010
Publication #:
Pub Dt:
03/31/2011
Title:
TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR OR ERYTHROPOIETIN PRODUCTION-INDUCING AGENT
3
Patent #:
Issue Dt:
12/17/2013
Application #:
12847025
Filing Dt:
07/30/2010
Publication #:
Pub Dt:
06/09/2011
Title:
NITROGEN-CONTAINING SPIROCYCLIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF
4
Patent #:
NONE
Issue Dt:
Application #:
14077446
Filing Dt:
11/12/2013
Publication #:
Pub Dt:
07/03/2014
Title:
NITROGEN-CONTAINING SPIROCYCLIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF
5
Patent #:
Issue Dt:
04/18/2017
Application #:
14184062
Filing Dt:
02/19/2014
Publication #:
Pub Dt:
01/22/2015
Title:
IRON (III) CITRATE, SUBSTANTIALLY FREE OF BETA-IRON HYDROXIDE OXIDE
6
Patent #:
NONE
Issue Dt:
Application #:
14749966
Filing Dt:
06/25/2015
Publication #:
Pub Dt:
05/26/2016
Title:
TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR OR ERYTHROPOIETIN PRODUCTION-INDUCING AGENT
7
Patent #:
NONE
Issue Dt:
Application #:
15030464
Filing Dt:
09/01/2016
Publication #:
Pub Dt:
12/22/2016
Title:
Therapeutic Agent for Ocular Disease or Prophylactic Agent for Ocular Disease
8
Patent #:
Issue Dt:
11/03/2020
Application #:
15741926
Filing Dt:
11/05/2018
Publication #:
Pub Dt:
02/28/2019
Title:
Method for Producing 7h-pyrrolo[2, 3-d]pyrimidine Derivative and Intermediate Thereof
9
Patent #:
NONE
Issue Dt:
Application #:
16396503
Filing Dt:
04/26/2019
Publication #:
Pub Dt:
03/19/2020
Title:
TRIAZINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
10
Patent #:
NONE
Issue Dt:
Application #:
16438694
Filing Dt:
06/12/2019
Publication #:
Pub Dt:
05/28/2020
Title:
TABLET CONTAINING FERRIC CITRATE
11
Patent #:
Issue Dt:
09/06/2022
Application #:
16463216
Filing Dt:
06/24/2020
Publication #:
Pub Dt:
10/29/2020
Title:
METHOD FOR PRODUCING TRIAZOLOPYRIDINE COMPOUND
12
Patent #:
Issue Dt:
04/26/2022
Application #:
16470843
Filing Dt:
02/07/2020
Publication #:
Pub Dt:
05/28/2020
Title:
PROCESS FOR PREPARING 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES AND CO-CRYSTALS THEREOF
13
Patent #:
Issue Dt:
05/24/2022
Application #:
16470854
Filing Dt:
06/18/2019
Publication #:
Pub Dt:
01/16/2020
Title:
CRYSTALLINE FORMS OF A JANUS KINASE INHIBITOR
14
Patent #:
NONE
Issue Dt:
Application #:
16807719
Filing Dt:
03/03/2020
Publication #:
Pub Dt:
01/28/2021
Title:
HYDROXYTRIAZINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
15
Patent #:
NONE
Issue Dt:
Application #:
16815472
Filing Dt:
03/11/2020
Publication #:
Pub Dt:
02/04/2021
Title:
IRON (III) CITRATE, SUBSTANTIALLY FREE OF BETA-IRON HYDROXIDE OXIDE
Assignor
1
Exec Dt:
03/04/2021
Assignee
1
1-1, TORANOMON 4-CHOME, MINATO-KU
TOKYO, JAPAN 105-6927
Correspondence name and address
JACK BRENNAN
FISH & RICHARDSON P.C.
P.O.BOX 1022
MINNEAPOLIS, MN 55440-1022

Search Results as of: 05/09/2024 04:38 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT